4.6 Article

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)

Related references

Note: Only part of the references are listed.
Article Neurosciences

Irritable bowel syndrome and Parkinson's disease risk: register-based studies

Bojing Liu et al.

Summary: The study found an increased risk of PD diagnosis after IBS, particularly 5 years and more than 10 years after diagnosis. However, there was no statistically significant association between IBS and PD risk in the twin cohort analysis.

NPJ PARKINSONS DISEASE (2021)

Article Multidisciplinary Sciences

Parkinson disease with constipation: clinical features and relevant factors

Qiu-Jin Yu et al.

SCIENTIFIC REPORTS (2018)

Article Gastroenterology & Hepatology

Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogs

Shinya Taniguchi et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Review Clinical Neurology

Constipation: an emerging risk factor for Parkinson's disease?

P. Stirpe et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Gastroenterology & Hepatology

Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV

Douglas A. Drossman

GASTROENTEROLOGY (2016)

Editorial Material Gastroenterology & Hepatology

Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction INTRODUCTION

Douglas A. Drossman et al.

GASTROENTEROLOGY (2016)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Review Clinical Neurology

Gastrointestinal dysfunction in Parkinson's disease

Alfonso Fasano et al.

LANCET NEUROLOGY (2015)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Review Pharmacology & Pharmacy

Management of constipation in Parkinson's disease

Malco Rossi et al.

EXPERT OPINION ON PHARMACOTHERAPY (2015)

Article Gastroenterology & Hepatology

Validity and reliability of the Japanese version of the Patient Assessment of Constipation Quality of Life questionnaire

Haruka Nomura et al.

JOURNAL OF GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

The role of bile acids in functional GI disorders

Richard N. Appleby et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2014)

Review Gastroenterology & Hepatology

Elobixibat and its potential role in chronic idiopathic constipation

Andres Acosta et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)

Article Health Care Sciences & Services

Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease

Megan K. Young et al.

QUALITY OF LIFE RESEARCH (2013)

Article Health Care Sciences & Services

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

M. Herdman et al.

QUALITY OF LIFE RESEARCH (2011)

Review Clinical Neurology

Gastrointestinal dysfunction in Parkinson's disease

RF Pfeiffer

LANCET NEUROLOGY (2003)

Article Gastroenterology & Hepatology

The proximal colonic motor response to rectal mechanical and chemical stimulation

PA Bampton et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)